Sherene Loi

83PUBLICATIONS
544CO-AUTHORS
Predictive and prognostic markersRadiation therapyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (83)

|Nov 03, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in colorectal carcinoma: a report on behalf of the International Immuno-Oncology Biomarker Working Group.

|Aug 26, 2026
Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial.

|May 18, 2026
The immunology of human breast cancer.

|Feb 05, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

Ylva A Weeda, Roberto Salgado, Filip van Herpe

|Feb 03, 2026
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer.

Soraia Lobo-Martins, Stephen J Luen, Martine Piccart

|Jan 08, 2026
DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer.

Komal Jhaveri, Sherene Loi, Erika Hamilton

Pageof 14

Frequent Collaborators

19 joint publications

Roberto Salgado

17 joint publications

Peter Savas

8 joint publications

Christos Sotiriou

7 joint publications

Giuseppe Curigliano